- 21531579OWN - NLMSTAT- MEDLINEDA  - 20110607DCOM- 20111003IS  - 1557-3117 (Electronic)IS  - 1053-2498 (Linking)VI  - 30IP  - 7DP  - 2011 JulTI  - Osteopontin: a potential biomarker for heart failure and reverse remodeling after      left ventricular assist device support.PG  - 805-10LID - 10.1016/j.healun.2011.03.015 [doi]AB  - BACKGROUND: Left ventricular assist device (LVAD) support in end-stage heart      failure (HF) leads to recovery of the patient's condition, size reduction of      cardiomyocytes, and also volume reduction and change in the composition of the      extracellular matrix (ECM). Myocardial expression of ECM osteopontin (OPN)      protein increases with the severity of HF. We analyzed whether OPN messenger RNA       expression in heart tissue and/or OPN protein in plasma are associated with      reverse remodeling during LVAD support. METHODS: Plasma and heart tissue      specimens of 22 end-stage HF patients before and after LVAD implantation and      subsequent heart transplantation (HTx) were used to determine the concentrations       of OPN protein (EIA) and OPN messenger RNA (mRNA) by quantitative polymerase      chain reaction. Immunohistochemistry (IHC) and in situ hybridization (ISH) were      performed to locate OPN protein and mRNA. RESULTS: The high OPN protein levels in      plasma of HF patients did not differ significantly before and after LVAD support       in ischemic heart disease (IHD) (pre-LVAD 167 +/- 32 ng/ml; post-LVAD 165 +/- 28       ng/ml) and in dilated cardiomyopathy (DCM) (pre-LVAD 99 +/- 12 ng/ml; post-LVAD      (142 +/- 6 ng/ml). The OPN plasma levels after HTx decreased to control levels      (IHD, 48 +/- 6; DCM, 40 +/- 5; control, 31 +/- 3 ng/ml). In contrast, expression       of OPN mRNA in heart biopsy specimens decreased significantly after LVAD support       (the relative quantity decreased > 90% in IHD and 50% in DCM). ISH and IHC      revealed that OPN was present in cardiomyocytes and in the ECM. CONCLUSIONS:      Levels of OPN mRNA in the myocardium of HF patients showed a significant decrease      after LVAD support but OPN protein expression did not. LVAD support only induced       a decrease of OPN plasma levels in individual patients, whereas OPN plasma levels      reduced significantly in all patients after HTx.CI  - Copyright (c) 2011 International Society for Heart and Lung Transplantation.      Published by Elsevier Inc. All rights reserved.FAU - Schipper, Marguerite E IAU  - Schipper MEAD  - Department of Pathology, University Medical Center Utrecht, Utrecht, The      Netherlands.FAU - Scheenstra, Maaike RAU  - Scheenstra MRFAU - van Kuik, JoyceAU  - van Kuik JFAU - van Wichen, Dick FAU  - van Wichen DFFAU - van der Weide, PetraAU  - van der Weide PFAU - Dullens, Hub F JAU  - Dullens HFFAU - Lahpor, JaapAU  - Lahpor JFAU - de Jonge, NicolaasAU  - de Jonge NFAU - De Weger, Roel AAU  - De Weger RALA  - engPT  - Journal ArticleDEP - 20110504PL  - United StatesTA  - J Heart Lung TransplantJT  - The Journal of heart and lung transplantation : the official publication of the      International Society for Heart TransplantationJID - 9102703RN  - 0 (Biological Markers)RN  - 0 (RNA, Messenger)RN  - 106441-73-0 (Osteopontin)SB  - IMMH  - Biological Markers/blood/metabolismMH  - Extracellular Matrix/metabolismMH  - Heart Failure/blood/*metabolism/*therapyMH  - Heart TransplantationMH  - *Heart-Assist Devices/adverse effectsMH  - HumansMH  - In Situ HybridizationMH  - Myocardium/metabolismMH  - Myocytes, Cardiac/metabolismMH  - Osteopontin/blood/genetics/*metabolismMH  - RNA, Messenger/blood/*metabolismMH  - Treatment OutcomeMH  - *Ventricular RemodelingEDAT- 2011/05/03 06:00MHDA- 2011/10/04 06:00CRDT- 2011/05/03 06:00PHST- 2010/11/26 [received]PHST- 2011/03/09 [revised]PHST- 2011/03/10 [accepted]PHST- 2011/05/04 [aheadofprint]AID - S1053-2498(11)00878-3 [pii]AID - 10.1016/j.healun.2011.03.015 [doi]PST - ppublishSO  - J Heart Lung Transplant. 2011 Jul;30(7):805-10. doi:      10.1016/j.healun.2011.03.015. Epub 2011 May 4.